Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
2022 · Cancer Discovery · 339 citations
https://doi.org/10.1158/2159-8290.cd-22-1066
R
Rina Sor
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
557
Citations
5
h-index
4
i10-index
Rina Sor is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Research and Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 5, co-authored 52 publications.
ORCID: 0000-0003-2042-5746Papers by this author
worksTumour-selective activity of RAS-GTP inhibition in pancreatic cancer
2024 · Nature · 157 citations
https://doi.org/10.1038/s41586-024-07379-z
T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma
2025 · Cancer Discovery · 26 citations
https://doi.org/10.1158/2159-8290.cd-24-1475
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat